Asthma in Youth and Early-onset Type 2 Diabetes: A Nationwide Study of 1.72 Million Israeli Adolescents.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
19 11 2021
Historique:
received: 29 12 2020
pubmed: 23 7 2021
medline: 30 12 2021
entrez: 22 7 2021
Statut: ppublish

Résumé

The prevalence of both asthma and early-onset diabetes is on the rise; however, the association between them remains unclear. We examined a possible association of asthma at adolescence with type 2 diabetes in young adulthood. This is a nationwide, population-based study of 1 718 541 Israeli adolescents (57% males; mean age 17.3 years; range 16-19 years), examined before compulsory military service between 1992 and 2016, with data linked to the Israeli National Diabetes Registry. Asthma diagnosis and severity were determined by a board-certified pulmonologist and based on spirometry tests. Type 2 diabetes developed in 58/9090 (0.64%), 507/97 059 (0.52%), 114/23 332 (0.49%), and 7095/1 589 060 (0.44%) persons with moderate-to-severe, mild, inactive, and no history of asthma, respectively, during a mean follow-up >13 years. The respective odds ratios (ORs) were 1.33 (95% CI, 1.02-1.74), 1.17 (1.06-1.28), and 1.09 (0.9-1.31), considering those without asthma history as the reference, in a model adjusted for birth year, sex, body mass index, and other sociodemographic variables. The association persisted when the analysis accounted for coexisting morbidities, and when persons without asthma, individually matched by age, sex, birth year, and body mass index were the reference. Both mild and moderate-to-severe asthma were associated with type 2 diabetes before age 35 years: ORs 1.18 (1.05-1.34) and 1.44 (1.05-2.00), respectively. The strength of the association was accentuated over time. The effect was unchanged when adjusted for oral and inhaled glucocorticoid use. Adolescents with active asthma have higher risk to develop type 2 diabetes. This seems related to disease severity, independent of adolescent obesity status, apparent before age 35 years, and more pronounced in recent years.

Sections du résumé

BACKGROUND
The prevalence of both asthma and early-onset diabetes is on the rise; however, the association between them remains unclear. We examined a possible association of asthma at adolescence with type 2 diabetes in young adulthood.
METHODS
This is a nationwide, population-based study of 1 718 541 Israeli adolescents (57% males; mean age 17.3 years; range 16-19 years), examined before compulsory military service between 1992 and 2016, with data linked to the Israeli National Diabetes Registry. Asthma diagnosis and severity were determined by a board-certified pulmonologist and based on spirometry tests.
RESULTS
Type 2 diabetes developed in 58/9090 (0.64%), 507/97 059 (0.52%), 114/23 332 (0.49%), and 7095/1 589 060 (0.44%) persons with moderate-to-severe, mild, inactive, and no history of asthma, respectively, during a mean follow-up >13 years. The respective odds ratios (ORs) were 1.33 (95% CI, 1.02-1.74), 1.17 (1.06-1.28), and 1.09 (0.9-1.31), considering those without asthma history as the reference, in a model adjusted for birth year, sex, body mass index, and other sociodemographic variables. The association persisted when the analysis accounted for coexisting morbidities, and when persons without asthma, individually matched by age, sex, birth year, and body mass index were the reference. Both mild and moderate-to-severe asthma were associated with type 2 diabetes before age 35 years: ORs 1.18 (1.05-1.34) and 1.44 (1.05-2.00), respectively. The strength of the association was accentuated over time. The effect was unchanged when adjusted for oral and inhaled glucocorticoid use.
CONCLUSION
Adolescents with active asthma have higher risk to develop type 2 diabetes. This seems related to disease severity, independent of adolescent obesity status, apparent before age 35 years, and more pronounced in recent years.

Identifiants

pubmed: 34291806
pii: 6325382
doi: 10.1210/clinem/dgab542
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e5043-e5053

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Michael Shapiro (M)

Department of Internal Medicine T, Tel Aviv Sourasky Medical Center, Tel Aviv 6492601, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Israel Defense Forces Medical Corps, Ramat Gan 5510802, Israel.

Chen Arbel (C)

Israel Defense Forces Medical Corps, Ramat Gan 5510802, Israel.
Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem 9112102, Israel.

Inbar Zucker (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
The Israel Center for Disease Control, Ministry of Health, Ramat Gan 5262160, Israel.

Gingy Ronen Balmor (GR)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Shamir (Assaf-Harofeh) Medical Center, Zerifin 70300, Israel.

Miri Lutski (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
The Israel Center for Disease Control, Ministry of Health, Ramat Gan 5262160, Israel.

Estela Derazne (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Zivan Beer (Z)

Israel Defense Forces Medical Corps, Ramat Gan 5510802, Israel.
Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem 9112102, Israel.

Orit Pinhas-Hamiel (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Department of Pediatric Endocrinology, Safra Children Hospital, Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.

Ofri Mosenzon (O)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel.

Dorit Tzur (D)

Israel Defense Forces Medical Corps, Ramat Gan 5510802, Israel.
Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem 9112102, Israel.

Arnon Afek (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Central Management, Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.

Amir Tirosh (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.

Tali Cukierman-Yaffe (T)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.

Hertzel C Gerstein (HC)

Department of Medicine, McMaster University, Hamilton, Ontario L8S 4M1, Canada.

Vered Rosenberg (V)

Maccabitech Research Institute, Maccabi Healthcare Services, Tel Aviv 6801296, Israel.

Gabriel Chodick (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Maccabitech Research Institute, Maccabi Healthcare Services, Tel Aviv 6801296, Israel.

Itamar Raz (I)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel.

Gilad Twig (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Israel Defense Forces Medical Corps, Ramat Gan 5510802, Israel.
Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem 9112102, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Ramat Gan 5266202, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH